학술논문

Idarucizumab (PRAXBIND®) as a sole reversal agent in an unstable hemorrhagic shock patient on an unknown anticoagulant with elevated protime/international normalized ratio (PT/INR).
Document Type
Article
Source
In: American Journal of Emergency Medicine. (American Journal of Emergency Medicine, August 2021, 46:800.e1-800.e3)
Subject
Language
English
ISSN
15328171
07356757